News
4 Next-Gen CNS Drug Development Trends
By Brian Buntz · October 24, 2022 · Drug Discovery & Development
News
Why Psychogenics and Emyria are Collaborating to Examine MDMA-Inspired Compounds
By Brian Buntz · Oct 12, 2022 · Drug Discovery & Development CNS-focused contract research organization PsychoGenics has forged a collaboration with clinical-stage...
News
Emyria Starts Program with Neuroscience Drug Discovery CRO
By Jim Cornall · Sept 22, 2022 · Labiotech.eu Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics,...
News
Clinical Catch-Up: Updates in Solid Tumors, ALS, Migraine and More
By Vanessa Doctor, RN · Sep 22, 2022 · BioSpace It’s been a busy week across the clinical development space, with...
News
Emyria teams with CRO PsychoGenics for MDMA-like Drug Development
By Joseph Keenan · Sep 21, 2022 · Fierce Biotech Australian biotech Emyria and U.S.-based CRO PsychoGenics have agreed to a collaborate on...